SCHEMBL30659433

SCHEMBL30659433

CC(C)(C)OC(=O)N1CCC(c2ccc3c(c2F)CCN3)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
GPR119 Q8TDV5 7/20 0.45
ALOX5AP P20292 1/20 0.43
FEN1 P39748 1/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
JAK3 P52333 1/20 0.41
DDB1 Q16531 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30659432 1.00 MAPT (0.46) MAPTKDM4ETHRBGPR119ALOX5AP
SCHEMBL31442861 1.00 MAPT (0.46) MAPTKDM4ETHRBGPR119ALOX5AP
SCHEMBL26100307 0.87 MAPK1 (0.50) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL30659439 0.85 THRB (0.46) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL30659271 0.82 THRB (0.47) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL30659256 0.80 MAPK1 (0.48) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL30659344 0.79 KDM4E (0.49) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL20438981 0.79 GPR119 (0.51) MAPTKDM4ETHRBGPR119ALOX5AP
SCHEMBL30844002 0.77 SMN1; SMN2 (0.51) MAPTKDM4ETHRBGPR119MAPK1
SCHEMBL31342284 0.77 STS (0.51) MAPTKDM4ETHRBGPR119ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536656-A1 BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS C4 Therapeutics, Inc. (US) 2025-04-16 EP disclosed
WO-2023239750-A1 BICYCLIC-SUBSTITUTED GLUTARIMIDE CEREBLON BINDERS C4 THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed